Considering the market share of vaccines against tick-borne encephalitis reported in Austria

Different market share values for TBE vaccines in Austria are reported during the period 2018–2020. However, both data likely cover a significant under-estimation of doses distributed. Thus, for epidemiological evaluations, market share should be used with prudence and only reported when solid whole...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Victoria A, Hoet, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282088/
https://www.ncbi.nlm.nih.gov/pubmed/35234876
http://dx.doi.org/10.1093/jtm/taac027
Descripción
Sumario:Different market share values for TBE vaccines in Austria are reported during the period 2018–2020. However, both data likely cover a significant under-estimation of doses distributed. Thus, for epidemiological evaluations, market share should be used with prudence and only reported when solid whole-market market share can be validated and referenced.

Ejemplares similares